Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 1, 2005, Pages 102-104

  Wieland, Thomas ^a,b   Liebold, Andreas ^a   Jagiello, Magda ^a   Retzl, Gerald ^b   Birnbaum, Dietrich E ^a  

^a Department of Cardiothoracic Surgery ^*  (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; CLARITHROMYCIN; PIPERACILLIN; SULBACTAM; TACROLIMUS; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; LUNG INFECTION; NEPHROTOXICITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECIPIENT; TREATMENT FAILURE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HEART TRANSPLANTATION; HUMANS; LUNG DISEASES, FUNGAL; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; TOMOGRAPHY, X-RAY COMPUTED; TRIAZOLES;

EID: 11844299571     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.10.014     Document Type: Article

References (10)

1. Singh N., Husain S. Aspergillus infections after lung transplantation clinical differences in type of transplant and implications for management. J Heart Lung Transplant. 22:2003;258-266
2. Safieddine N., Taylor B.M., Guiraurdon C.M. Small bowel infarction secondary to aspergillosis in a post-cardiac transplant patient a case report. J Heart Lung Transplant. 21:2002;935-937
3. Kullberg B.J., Oude Lashof A.M. Epidemiology of opportunistic invasive mycoses. Eur J Med Res. 7:2002;183-191
4. Denning D.W. Invasive aspergillosis. Clin Infect Dis. 26:1998;781-785
5. Stevens D.A., Kan V.L., Judson M.A., et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis. 30:2000;696-709
6. Wingard J.R., Kubilis P., Lee L., et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis. 29:1999;1402-1407
7. Bates D.W., Su L., Yu D.T., et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 32:2001;686-693
8. Herbrecht R., Denning D.W., Patterson T.F., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 347:2002;408-415
9. Ghannoum M.A., Kuhn D.M. Voriconazole - better chances for patients with invasive mycoses. Eur J Med Res. 7:2002;242-256
10. Soubani A.O., Chandrasekar P.H. The clinical spectrum of pulmonary aspergillosis. Chest. 121:2002;1988-1999